Scientists uncover structure and operating mechanism of TPPII

Apr 5 2012

Uncontrolled or inaccurate degradation of cellular proteins can lead to diseases like cancer or Alzheimer's disease. Scientists of the Max Planck Institute of Biochemistry (MPIB) in Martinsried near Munich, Germany, have now uncovered the structure and the operating mechanism of an important component of the human cellular degradation machinery, tripeptidyl peptidase II (TPPII). "Decoding the structure of TPPII is a crucial milestone towards understanding the complex activation and control of protein degradation", says Beate Rockel, scientist at the MPIB. The results of the study have now been published in the journal Structure.

Proteins, the molecular building blocks and machines of the cell, are composed of long chains of amino acids. When such a chain has to be degraded, it is first unfolded and then cleaved into shorter pieces, so-called peptides. Tripeptidyl peptidase II (TPPII), which was analyzed by scientists in the department of MPIB director Wolfgang Baumeister, is one of the factors that take over further degradation. It chops the peptides into even smaller bits which, after some additional steps, can be recycled for the assembly of new proteins. TPPII is a large complex consisting of 32 to 40 identical subunits, which are inactive on their own. The complex becomes functional, when the subunits join into two strands twisted around each other. The complex is approximately 100 times larger than most other protein-degrading enzymes. "TPPII is a real giant amongst cellular proteins", says PhD student Anne-Marie Schönegge. "Solving the structure of such a colossus is a difficult task."

Bit by Bit towards the Complete Structure

The researchers of the MPIB combined different methods of structural biology and models to determine the structure and operating mechanism of TPPII in detail. In collaboration with scientists from the Lawrence Berkeley National Laboratory in Berkeley, they had successfully solved the atomic structure of TPPII-subunits of the fruit fly by X-ray-crystallography. In a subsequent step, this structure served as the basis to calculate a model of human TPPII-subunits.

Using cryoelectron microscopy and single-particle reconstruction, the scientists were able to determine the structure of complete and active TPPII-complexes of the fruit fly and humans - but only at medium resolution. By combining the structure of the complete complexes with the more detailed atomic models of individual subunits, the co-workers of the research department "Molecular Structural Biology" could now solve the detailed structural organization of human TPPII: the subunits enclose a cavity system which traverses the whole TPPII complex and harbors the catalytic sites.

By fitting the structures of the inactive subunits into the structure of the active complex, the scientists pinpointed regions that are supposed to undergo changes upon activation of TPPII. These regions include the active site and the entrances into the cavity-system inside the complex. Beate Rockel also hopes for other benefits out of this work: "Insights into the TPPII structure could contribute to the development of new drugs in the future, since there are indications that TPPII may be involved in diseases such as muscle wasting, adiposis and cancer."